GABAergic and Glutamatergic Afferents in the Dorsal Raphe Nucleus Mediate Morphine-Induced Increases in Serotonin Efflux in the Rat Central Nervous System-Reference-Cited by-同舟云学术

GABAergic and Glutamatergic Afferents in the Dorsal Raphe Nucleus Mediate Morphine-Induced Increases in Serotonin Efflux in the Rat Central Nervous System

Published:2002-11-01 Issue:2 Volume:303 Page:704-710
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Tao Rui,Auerbach Sidney B.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference38 articles.

1. Dual control of dorsal raphe serotonergic neurons by GABAB receptors. Electrophysiological and microdialysis studies

2. Serotonin-facilitated dopamine release in vivo: pharmacological characterization.;Benloucif;J Pharmacol Exp Ther,1993

3. Endogenous activation of μ and δ-1 opioid receptors is required for long-term potentiation induction in the lateral perforant path: dependence on GABAergic inhibition.;Bramham;J Neurosci,1996

4. 5HT3 receptor antagonists block morphine- and nicotine-but not amphetamine-induced reward

5. Evidence that 5-hydroxytryptamine in the forebrain is involved in naloxone-precipitated jumping in morphine-dependent rats.;Cervo;Br J Pharmacol,1983

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resolution of tonic concentrations of highly similar neurotransmitters using voltammetry and deep learning;Molecular Psychiatry;2024-04-25

2. Mu Opioid Receptor–Expressing Neurons in the Dorsal Raphe Nucleus Are Involved in Reward Processing and Affective Behaviors;Biological Psychiatry;2023-12

3. Mu Opioid Receptor–Positive Neurons in the Dorsal Raphe Nucleus Are Impaired by Morphine Abstinence;Biological Psychiatry;2023-12

4. The Dorsal Raphe as a Regulator of Emotion and Reward: Beyond Pain;Biological Psychiatry;2023-12

5. μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges;Frontiers in Pharmacology;2023-10-11